ScreenerHero
LABSMediPharm Labs Corp.
TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · medipharmlabs.com
0.0750CAD0.00%Mkt Cap: 23.21M $P/E: —

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Cana…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap23.21M $
Enterprise Value16.05M $
Revenue (TTM)30.19M $
Gross Profit10.17M $
Net Income (TTM)-6.02M $
Revenue/Share0.0714 USD
Last Price0.0750 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees127
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58504D1006
Valuation
P/E (Trailing)—
P/E (Forward)-7.50
PEG—
EV/EBITDA-9.14
EV/Revenue0.53
P/S0.77
P/B0.90
EPS (TTM)-0.02
EPS (Forward)-0.01
52W Range
0.060038% of range0.1000
52W High0.1000 CAD
52W Low0.0600 CAD
Profitability
Gross Margin30.95%
Oper. Margin0.82%
EBITDA Margin-5.82%
Profit Margin-18.32%
ROE-23.08%
ROA-18.07%
Growth
Revenue Growth-15.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.01M $
CapEx (TTM)72.83K $
FCF Margin4.97%
FCF Yield6.46%
Net Debt-7.28M $
Net Debt/EBITDA4.15
Balance Sheet
Debt/Equity0.01
Current Ratio2.69
Quick Ratio1.68
Book Value/Sh0.0830 CAD
Cash/Share0.0240 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.427.18M
Float390.00M
Insiders11.64%
Institutions0.00%
Short Interest
Short Ratio1.2d
Short % Out.0.06%
Shares Short277.19K
Short (prev mo.)198.26K
Technical
SMA 500.0742 (+1.1%)
SMA 2000.0715 (+4.9%)
Beta0.93
S&P 52W Chg18.16%
Avg Vol (30d)208.13K
Avg Vol (10d)216.72K
Technical Indicators
RSI (14)49.2
MACD0.0001
MACD Signal0.0002
MACD Hist.-0.0001
BB Upper0.0812 CAD
BB Middle0.0760 CAD
BB Lower0.0708 CAD
BB Width13.77%
ATR (14)0.0053 CAD
Vol Ratio (20d)0.52x